aluates Reports

$ 0.0

Automative

Global Tuberculosis (TB) Diagnostics Market Research Report 2026

Published Date: 2026-01-16

Report Code: QYRE-Auto-27F8907

Global Tuberculosis TB Diagnostics Market Size Status and Forecast 2022

BUY CHAPTERS

Global Tuberculosis (TB) Diagnostics Market Research Report 2026

Code: QYRE-Auto-27F8907

Report

2026-01-16

Pages:110

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Danaher

Roche

Thermo Fisher Scientific

Abbott

Hologic Inc

Qiagen NV

Biomerieux

Hain Lifescience

Oxford Immunotec

Tuberculosis (TB) Diagnostics Market Size

The global Tuberculosis (TB) Diagnostics market was valued at US$ 3186 million in 2025 and is anticipated to reach US$ 4318 million by 2032, at a CAGR of 4.5% from 2026 to 2032.

Tuberculosis (TB) Diagnostics Market

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.

The global TB diagnostics market is being propelled by the urgent need to improve disease detection and control in response to the persistent burden of tuberculosis, particularly in high-prevalence regions. Efforts to reach WHO’s End TB goals have elevated funding for TB programs, driving the rollout of advanced diagnostic tools like molecular assays , X‑ray based screening solutions with AI assistance, and point-of-care tests. Furthermore, increasing integration of TB screening within broader healthcare initiatives—such as universal healthcare coverage and integrated respiratory disease programs—has expanded testing capacity. The push to screen high-risk populations, including people living with HIV, healthcare workers, migrants, and prison inmates, has also increased demand for rapid, accurate, and decentralized diagnostic methods capable of delivering same-day results and guiding treatment decisions.

Despite significant advancements in TB diagnostics, substantial barriers continue to hinder market expansion. One major challenge is inconsistent access to cutting-edge diagnostic tools in low- and middle-income countries, where infrastructure remains limited and centralized laboratory systems struggle to support widespread deployment. Additionally, the cost of advanced molecular and imaging technologies remains a deterrent, particularly when factoring in expenses for equipment maintenance, consumables, and the specialized training required for healthcare personnel. The regulatory and logistical complexities involved in distributing diagnostic platforms—especially in remote rural areas—also slow down adoption. Finally, the co-existence of disparate diagnostic algorithms across countries, combined with variable healthcare funding and weak supply chain systems, continues to limit consistent implementation of guideline-compliant testing and undermines efforts to significantly reduce TB incidence.

Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%. APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.

This report delivers a comprehensive overview of the global Tuberculosis (TB) Diagnostics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Tuberculosis (TB) Diagnostics. The Tuberculosis (TB) Diagnostics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Tuberculosis (TB) Diagnostics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Tuberculosis (TB) Diagnostics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Tuberculosis (TB) Diagnostics Market Report

Report Metric	Details
Report Name	Tuberculosis (TB) Diagnostics Market
Accounted market size in 2025	US$ 3186 million
Forecasted market size in 2032	US$ 4318 million
CAGR	4.5%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Culture-Based Diagnostics Sputum Smear Microscopy Rapid Molecular Diagnostics Others
Segment by Application	Diagnostic Laboratories Hospitals
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux, Hain Lifescience, Oxford Immunotec
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Tuberculosis (TB) Diagnostics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Tuberculosis (TB) Diagnostics Market growing?

Ans: The Tuberculosis (TB) Diagnostics Market witnessing a CAGR of 4.5% during the forecast period 2026-2032.

What is the Tuberculosis (TB) Diagnostics Market size in 2032?

Ans: The Tuberculosis (TB) Diagnostics Market size in 2032 will be US$ 4318 million.

What is the market share of major companies in Tuberculosis (TB) Diagnostics Market?

Ans: Global top five manufacturers hold a share about 33%.

Who are the main players in the Tuberculosis (TB) Diagnostics Market report?

Ans: The main players in the Tuberculosis (TB) Diagnostics Market are Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, Hologic, Qiagen, BioMerieux, Hain Lifescience, Oxford Immunotec

What are the Application segmentation covered in the Tuberculosis (TB) Diagnostics Market report?

Ans: The Applications covered in the Tuberculosis (TB) Diagnostics Market report are Diagnostic Laboratories, Hospitals

What are the Type segmentation covered in the Tuberculosis (TB) Diagnostics Market report?

Ans: The Types covered in the Tuberculosis (TB) Diagnostics Market report are Culture-Based Diagnostics, Sputum Smear Microscopy, Rapid Molecular Diagnostics, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Culture-Based Diagnostics

1.2.3 Sputum Smear Microscopy

1.2.4 Rapid Molecular Diagnostics

1.2.5 Others

1.3 Market by Application

1.3.1 Global Tuberculosis (TB) Diagnostics Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Diagnostic Laboratories

1.3.3 Hospitals

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tuberculosis (TB) Diagnostics Market Perspective (2021–2032)

2.2 Global Tuberculosis (TB) Diagnostics Growth Trends by Region

2.2.1 Global Tuberculosis (TB) Diagnostics Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Tuberculosis (TB) Diagnostics Historic Market Size by Region (2021–2026)

2.2.3 Tuberculosis (TB) Diagnostics Forecasted Market Size by Region (2027–2032)

2.3 Tuberculosis (TB) Diagnostics Market Dynamics

2.3.1 Tuberculosis (TB) Diagnostics Industry Trends

2.3.2 Tuberculosis (TB) Diagnostics Market Drivers

2.3.3 Tuberculosis (TB) Diagnostics Market Challenges

2.3.4 Tuberculosis (TB) Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue

3.1.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue (2021–2026)

3.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Players (2021–2026)

3.2 Global Top Tuberculosis (TB) Diagnostics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Tuberculosis (TB) Diagnostics Revenue

3.4 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio

3.4.1 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis (TB) Diagnostics Revenue in 2025

3.5 Global Key Players of Tuberculosis (TB) Diagnostics Head Offices and Areas Served

3.6 Global Key Players of Tuberculosis (TB) Diagnostics, Products and Applications

3.7 Global Key Players of Tuberculosis (TB) Diagnostics, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Tuberculosis (TB) Diagnostics Breakdown Data by Type

4.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Type (2021–2026)

4.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2027–2032)

5 Tuberculosis (TB) Diagnostics Breakdown Data by Application

5.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Application (2021–2026)

5.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Tuberculosis (TB) Diagnostics Market Size (2021–2032)

6.2 North America Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Tuberculosis (TB) Diagnostics Market Size by Country (2021–2026)

6.4 North America Tuberculosis (TB) Diagnostics Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Tuberculosis (TB) Diagnostics Market Size (2021–2032)

7.2 Europe Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2021–2026)

7.4 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size (2021–2032)

8.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2021–2026)

8.4 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Tuberculosis (TB) Diagnostics Market Size (2021–2032)

9.2 Latin America Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2021–2026)

9.4 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size (2021–2032)

10.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2021–2026)

10.4 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Danaher

11.1.1 Danaher Company Details

11.1.2 Danaher Business Overview

11.1.3 Danaher Tuberculosis (TB) Diagnostics Introduction

11.1.4 Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2021–2026)

11.1.5 Danaher Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Tuberculosis (TB) Diagnostics Introduction

11.2.4 Roche Revenue in Tuberculosis (TB) Diagnostics Business (2021–2026)

11.2.5 Roche Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Details

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Introduction

11.3.4 Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2021–2026)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 BD

11.4.1 BD Company Details

11.4.2 BD Business Overview

11.4.3 BD Tuberculosis (TB) Diagnostics Introduction

11.4.4 BD Revenue in Tuberculosis (TB) Diagnostics Business (2021–2026)

11.4.5 BD Recent Development

11.5 Abbott

11.5.1 Abbott Company Details

11.5.2 Abbott Business Overview

11.5.3 Abbott Tuberculosis (TB) Diagnostics Introduction

11.5.4 Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2021–2026)

11.5.5 Abbott Recent Development

11.6 Hologic

11.6.1 Hologic Company Details

11.6.2 Hologic Business Overview

11.6.3 Hologic Tuberculosis (TB) Diagnostics Introduction

11.6.4 Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2021–2026)

11.6.5 Hologic Recent Development

11.7 Qiagen

11.7.1 Qiagen Company Details

11.7.2 Qiagen Business Overview

11.7.3 Qiagen Tuberculosis (TB) Diagnostics Introduction

11.7.4 Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2021–2026)

11.7.5 Qiagen Recent Development

11.8 BioMerieux

11.8.1 BioMerieux Company Details

11.8.2 BioMerieux Business Overview

11.8.3 BioMerieux Tuberculosis (TB) Diagnostics Introduction

11.8.4 BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2021–2026)

11.8.5 BioMerieux Recent Development

11.9 Hain Lifescience

11.9.1 Hain Lifescience Company Details

11.9.2 Hain Lifescience Business Overview

11.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Introduction

11.9.4 Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2021–2026)

11.9.5 Hain Lifescience Recent Development

11.10 Oxford Immunotec

11.10.1 Oxford Immunotec Company Details

11.10.2 Oxford Immunotec Business Overview

11.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Introduction

11.10.4 Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2021–2026)

11.10.5 Oxford Immunotec Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Danaher

Roche

Thermo Fisher Scientific

Abbott

Hologic Inc

Qiagen NV

Biomerieux

Hain Lifescience

Oxford Immunotec

List of Tables

Table 1. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Culture-Based Diagnostics

Table 3. Key Players of Sputum Smear Microscopy

Table 4. Key Players of Rapid Molecular Diagnostics

Table 5. Key Players of Others

Table 6. Global Tuberculosis (TB) Diagnostics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Tuberculosis (TB) Diagnostics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Tuberculosis (TB) Diagnostics Market Size by Region (US$ Million), 2021–2026

Table 9. Global Tuberculosis (TB) Diagnostics Market Share by Region (2021–2026)

Table 10. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Tuberculosis (TB) Diagnostics Market Share by Region (2027–2032)

Table 12. Tuberculosis (TB) Diagnostics Market Trends

Table 13. Tuberculosis (TB) Diagnostics Market Drivers

Table 14. Tuberculosis (TB) Diagnostics Market Challenges

Table 15. Tuberculosis (TB) Diagnostics Market Restraints

Table 16. Global Tuberculosis (TB) Diagnostics Revenue by Players (US$ Million), 2021–2026

Table 17. Global Tuberculosis (TB) Diagnostics Market Share by Players (2021–2026)

Table 18. Global Top Tuberculosis (TB) Diagnostics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Tuberculosis (TB) Diagnostics Revenue, 2025

Table 19. Ranking of Global Top Tuberculosis (TB) Diagnostics Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Tuberculosis (TB) Diagnostics Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Tuberculosis (TB) Diagnostics, Headquarters and Area Served

Table 22. Global Key Players of Tuberculosis (TB) Diagnostics, Products and Applications

Table 23. Global Key Players of Tuberculosis (TB) Diagnostics, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Tuberculosis (TB) Diagnostics Market Size by Type (US$ Million), 2021–2026

Table 26. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2021–2026)

Table 27. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2027–2032)

Table 29. Global Tuberculosis (TB) Diagnostics Market Size by Application (US$ Million), 2021–2026

Table 30. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2021–2026)

Table 31. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2027–2032)

Table 33. North America Tuberculosis (TB) Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Tuberculosis (TB) Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 35. North America Tuberculosis (TB) Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Tuberculosis (TB) Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Tuberculosis (TB) Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Tuberculosis (TB) Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Tuberculosis (TB) Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Tuberculosis (TB) Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Tuberculosis (TB) Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (US$ Million), 2027–2032

Table 48. Danaher Company Details

Table 49. Danaher Business Overview

Table 50. Danaher Tuberculosis (TB) Diagnostics Product

Table 51. Danaher Revenue in Tuberculosis (TB) Diagnostics Business (US$ Million), 2021–2026

Table 52. Danaher Recent Development

Table 53. Roche Company Details

Table 54. Roche Business Overview

Table 55. Roche Tuberculosis (TB) Diagnostics Product

Table 56. Roche Revenue in Tuberculosis (TB) Diagnostics Business (US$ Million), 2021–2026

Table 57. Roche Recent Development

Table 58. Thermo Fisher Scientific Company Details

Table 59. Thermo Fisher Scientific Business Overview

Table 60. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product

Table 61. Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (US$ Million), 2021–2026

Table 62. Thermo Fisher Scientific Recent Development

Table 63. BD Company Details

Table 64. BD Business Overview

Table 65. BD Tuberculosis (TB) Diagnostics Product

Table 66. BD Revenue in Tuberculosis (TB) Diagnostics Business (US$ Million), 2021–2026

Table 67. BD Recent Development

Table 68. Abbott Company Details

Table 69. Abbott Business Overview

Table 70. Abbott Tuberculosis (TB) Diagnostics Product

Table 71. Abbott Revenue in Tuberculosis (TB) Diagnostics Business (US$ Million), 2021–2026

Table 72. Abbott Recent Development

Table 73. Hologic Company Details

Table 74. Hologic Business Overview

Table 75. Hologic Tuberculosis (TB) Diagnostics Product

Table 76. Hologic Revenue in Tuberculosis (TB) Diagnostics Business (US$ Million), 2021–2026

Table 77. Hologic Recent Development

Table 78. Qiagen Company Details

Table 79. Qiagen Business Overview

Table 80. Qiagen Tuberculosis (TB) Diagnostics Product

Table 81. Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (US$ Million), 2021–2026

Table 82. Qiagen Recent Development

Table 83. BioMerieux Company Details

Table 84. BioMerieux Business Overview

Table 85. BioMerieux Tuberculosis (TB) Diagnostics Product

Table 86. BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (US$ Million), 2021–2026

Table 87. BioMerieux Recent Development

Table 88. Hain Lifescience Company Details

Table 89. Hain Lifescience Business Overview

Table 90. Hain Lifescience Tuberculosis (TB) Diagnostics Product

Table 91. Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (US$ Million), 2021–2026

Table 92. Hain Lifescience Recent Development

Table 93. Oxford Immunotec Company Details

Table 94. Oxford Immunotec Business Overview

Table 95. Oxford Immunotec Tuberculosis (TB) Diagnostics Product

Table 96. Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (US$ Million), 2021–2026

Table 97. Oxford Immunotec Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Tuberculosis (TB) Diagnostics Picture

Figure 2. Global Tuberculosis (TB) Diagnostics Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Tuberculosis (TB) Diagnostics Market Share by Type: 2025 vs 2032

Figure 4. Culture-Based Diagnostics Features

Figure 5. Sputum Smear Microscopy Features

Figure 6. Rapid Molecular Diagnostics Features

Figure 7. Others Features

Figure 8. Global Tuberculosis (TB) Diagnostics Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Tuberculosis (TB) Diagnostics Market Share by Application: 2025 vs 2032

Figure 10. Diagnostic Laboratories Case Studies

Figure 11. Hospitals Case Studies

Figure 12. Tuberculosis (TB) Diagnostics Report Years Considered

Figure 13. Global Tuberculosis (TB) Diagnostics Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Tuberculosis (TB) Diagnostics Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Tuberculosis (TB) Diagnostics Market Share by Region: 2025 vs 2032

Figure 16. Global Tuberculosis (TB) Diagnostics Market Share by Players in 2025

Figure 17. Global Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Tuberculosis (TB) Diagnostics Revenue in 2025

Figure 19. North America Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Tuberculosis (TB) Diagnostics Market Share by Country (2021–2032)

Figure 21. United States Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Tuberculosis (TB) Diagnostics Market Share by Country (2021–2032)

Figure 25. Germany Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Tuberculosis (TB) Diagnostics Market Share by Region (2021–2032)

Figure 33. China Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Tuberculosis (TB) Diagnostics Market Share by Country (2021–2032)

Figure 41. Mexico Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Tuberculosis (TB) Diagnostics Market Share by Country (2021–2032)

Figure 45. Israel Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Tuberculosis (TB) Diagnostics Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Danaher Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2021–2026)

Figure 49. Roche Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2021–2026)

Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2021–2026)

Figure 51. BD Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2021–2026)

Figure 52. Abbott Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2021–2026)

Figure 53. Hologic Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2021–2026)

Figure 54. Qiagen Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2021–2026)

Figure 55. BioMerieux Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2021–2026)

Figure 56. Hain Lifescience Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2021–2026)

Figure 57. Oxford Immunotec Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2021–2026)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Tuberculosis Vaccines Market Research Report 2024

Tuberculosis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tuberculosis TB Detection Market Research Report 2024

Global Mycobacterium Tuberculosis Testing Market Research Report 2024

Tuberculosis Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tuberculosis Vaccination Market Research Report 2025

Global TB Disease Vaccine Market Research Report 2025

Global BCG and Tuberculosis Vaccine Market Research Report 2025

Global Anti tuberculosis Therapeutics Market Insights Forecast to 2030

TB Vaccine Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Tuberculosis Testing and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mycobacterium Tuberculosis Detection Kits Market Research Report 2025

BCG Tuberculosis TB Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

VPM1002 Tuberculosis BCG Based Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Latent TB Detection Market Research Report 2024

Global BCG Vaccine Market Insights Forecast to 2030

Global BCG Vaccination Market Research Report 2025

Global BCG Vaccine for Tuberculosis TB Market Research Report 2025

Latent Tuberculosis Infection Screening Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions